Nicolet Advisory Services LLC Has $360,000 Stake in Humana Inc. (NYSE:HUM)

Nicolet Advisory Services LLC lowered its stake in shares of Humana Inc. (NYSE:HUM) by 46.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,137 shares of the insurance provider’s stock after selling 991 shares during the quarter. Nicolet Advisory Services LLC’s holdings in Humana were worth $360,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in HUM. Swedbank AB grew its holdings in shares of Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after purchasing an additional 3,085 shares in the last quarter. Ontario Teachers Pension Plan Board grew its stake in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares in the last quarter. Heritage Oak Wealth Advisors LLC bought a new position in Humana in the 2nd quarter valued at about $3,456,000. Mandatum Life Insurance Co Ltd raised its position in shares of Humana by 115.4% in the 3rd quarter. Mandatum Life Insurance Co Ltd now owns 14,000 shares of the insurance provider’s stock valued at $4,434,000 after buying an additional 7,500 shares in the last quarter. Finally, APG Asset Management US Inc. lifted its holdings in shares of Humana by 3.0% during the 2nd quarter. APG Asset Management US Inc. now owns 67,669 shares of the insurance provider’s stock worth $25,274,000 after acquiring an additional 1,955 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Stock Up 0.8 %

Humana stock opened at $298.11 on Friday. The firm has a market cap of $35.90 billion, a price-to-earnings ratio of 26.40, a PEG ratio of 2.33 and a beta of 0.52. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $527.18. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50 day moving average price of $276.83 and a two-hundred day moving average price of $330.68.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities analysts predict that Humana Inc. will post 15.86 EPS for the current year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.19%. Humana’s payout ratio is 31.36%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on HUM. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Wells Fargo & Company lowered their price target on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Royal Bank of Canada reduced their price objective on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price for the company in a research note on Tuesday, October 8th. Finally, Piper Sandler downgraded shares of Humana from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.